Evidence review Hydroxyapatite

Sensitive teeth: four ingredients help modestly, and none clearly wins

Written by Claire Watts · Reviewed by Marcus Hale, DDS · Updated Jul 22, 2026 · 8 studies cited

Key takeaways

·Potassium nitrate, arginine, stannous fluoride, and hydroxyapatite have all reduced sensitivity in randomized trials; the differences between them are small.
·The placebo response in this field is unusually large. Expect modest relief building over 2–8 weeks of twice-daily use, not an off switch.
·Sensitivity that is new, one-sided, or getting worse can signal a crack, decay, or a gum problem — that's a dentist visit, not a toothpaste decision.

Questions this review answers

Why are my teeth sensitive to hot and cold? → Do sensitivity toothpastes work? → When is sensitivity a dentist problem? →

What we reviewed

Randomized trials and systematic reviews of toothpaste ingredients tested for dentin hypersensitivity — the short, sharp pain from cold, sweet, or touch on exposed root surfaces. Eight sources met our bar: one network meta-analysis across ingredient classes, one Cochrane review, two randomized trials, one pooled analysis, and three context papers on mechanism. Trials of in-office treatments (varnishes, lasers, bonding) were out of scope; those are dentist decisions.

Why teeth get sensitive

Under enamel sits dentin, and dentin is full of microscopic fluid-filled channels that run toward the nerve. When gums recede or enamel wears, those channels open to the mouth. Cold or sugary stimuli move the fluid, and the nerve reads that movement as pain. Every ingredient below works one of two ways: numbing the nerve's response (potassium) or plugging the open channels (arginine, stannous fluoride, hydroxyapatite, calcium sodium phosphosilicate).

What the trials show

A network meta-analysis across desensitizing toothpastes found most active ingredients modestly better than placebo, with no clearly superior class — the differences between actives were smaller than the differences between trial designs.

Martins et al. · J Dent Res · 2020 · Network meta-analysis

In an 8-week four-arm trial, 10% and 15% nano-hydroxyapatite pastes reduced sensitivity as well as calcium sodium phosphosilicate, a leading desensitizer — all arms improved significantly from baseline.

Amaechi et al. · BDJ Open · 2021 · RCT

Pooled across eight randomized trials, hydroxyapatite reduced sensitivity roughly 40% more than placebo. Potassium nitrate — the classic "sensitivity toothpaste" active, used at 5% — has the longest history but surprisingly soft footing: the Cochrane review of potassium pastes found the trials small and the overall effect uncertain. It clearly helps some people; the research just can't yet say how much of that is the ingredient.

Amounts used in the studies

These are amounts used in published studies, not recommendations. Potassium nitrate: 5%, the standard level in US sensitivity pastes. Arginine: 8%. Hydroxyapatite: 10–15%. Stannous fluoride: 0.45%. In all cases: brushing twice daily, with most trials measuring relief between 2 and 8 weeks. If a paste hasn't helped after 8 weeks of consistent use, the trials suggest switching mechanisms — from a nerve-calming active to a channel-plugging one, or the reverse.

Limitations

Pain is self-reported, so these trials are only as good as their blinding — and brushing with any paste tends to help, which inflates every arm. Trials are short (rarely past 8 weeks), many are manufacturer-funded, and measurement scales vary enough that pooling is rough. Treat the rankings as soft and the placebo-beating findings as the durable part.

Bottom line

Pick one active, use it twice daily, and give it 4–8 weeks before judging. Potassium nitrate, arginine, stannous fluoride, and hydroxyapatite are all reasonable, evidence-backed choices; none is a clear winner. Rule out causes first: get new or worsening sensitivity looked at by a dentist before treating it as a product problem — and mention it at your next visit either way.

References

Update history

Jul 2026 — Added the 2021 four-arm nano-hydroxyapatite trial; reframed potassium nitrate around the Cochrane findings.
Apr 2026 — First published.

How we handle updates and corrections →